12 Health Care Stocks Moving In Wednesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's after-market session, several health care stocks experienced significant price movements. Molecular Templates (MTEM) saw a remarkable increase of 189.2%, while HCW Biologics (HCWB) experienced a notable decline of 14.8%. Other gainers included Klotho Neurosciences (KLTO) and Chromocell Therapeutics (CHRO), while Biodexa Pharmaceuticals (BDRX) and Capricor Therapeutics (CAPR) were among the losers.
October 16, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Chromocell Therapeutics (CHRO) shares increased by 12.23% in after-market trading, with a market cap of $5.7 million.
CHRO's stock price gain indicates positive sentiment, potentially leading to further short-term gains.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 80
POSITIVE IMPACT
Klotho Neurosciences (KLTO) stock rose by 21.72% in after-market trading, increasing its market cap to $14.5 million.
KLTO's price increase suggests positive developments or investor interest, likely supporting short-term upward movement.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Molecular Templates (MTEM) stock surged by 189.2% in after-market trading, significantly increasing its market cap to $6.1 million.
MTEM's significant price increase suggests positive investor sentiment or news, likely leading to continued short-term upward momentum.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Biodexa Pharmaceuticals (BDRX) shares decreased by 12.74% in after-market trading, with a market cap of $106.4 million.
BDRX's decline suggests negative sentiment or news, likely resulting in continued short-term downward pressure.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 80
NEGATIVE IMPACT
Capricor Therapeutics (CAPR) stock decreased by 11.07% in after-market trading, reducing its market cap to $644.5 million.
CAPR's stock price decline indicates negative sentiment, likely leading to further short-term downward movement.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
HCW Biologics (HCWB) shares fell 14.8% in after-market trading, reducing its market cap to $20.4 million.
The sharp decline in HCWB's stock price indicates negative sentiment or adverse news, likely leading to further short-term downward pressure.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100